77S-82506-61833
3 vaccinations
3 coded responses
35 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 200 / DC
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Pfizer-BioNTech
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-20
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Sleep disorder — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Interrupted sleepMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-05-01
- 2021-05-06
- 2021-05-13
- 2021-07-01
- 2021-10-02
-
2021-12-07
Dose 3 — Pfizer-BioNTech
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-09
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Armpit painMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-12
-
2021-12-13
Survey response — days 1–6 daily, dose 3MedDRA: Heart rate increased — Feeling: Good · Fatigue or tirednessFree text: Elevated heart rateMedDRA releases: 2024-11 · check-in free text available
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-03-08
- 2022-06-07
- 2022-12-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-12-07 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Interrupted sleep
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Armpit pain
Systemic reaction (other): Elevated heart rate
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Sleep disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release